These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4486599)

  • 41. [Ophthalmic use of amikacin (author's transl)].
    Oishi M; Nakatsue T; Nishizuka K; Motoyama M
    Jpn J Antibiot; 1974 Apr; 27(2):238-43. PubMed ID: 4211537
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.
    Molavi A; Barza M; Cole W; Berman H; Weinstein L
    Chemotherapy; 1973; 18(1):7-16. PubMed ID: 4485185
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Carbenicillin. Experimental studies on the antibacterial activity and clinical pharmacology].
    Naumann P; Kempf J
    Arzneimittelforschung; 1969 Aug; 19(8):1222-33. PubMed ID: 4980237
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of amikacin and gentamicin.
    Klastersky J; Odio W; Hensgens C
    Clin Pharmacol Ther; 1975 Mar; 17(3):348-54. PubMed ID: 804370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tobramycin-gentamicin: the To-Ge pretext of aminoside antibiotics].
    Morel C; Freymuth F
    Nouv Presse Med; 1973 Jan; 2(4):246. PubMed ID: 4568329
    [No Abstract]   [Full Text] [Related]  

  • 47. [Susceptibility of pathogens isolated from clinical specimens to lividomycin].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1972 Dec; 25(6):343-6. PubMed ID: 4353339
    [No Abstract]   [Full Text] [Related]  

  • 48. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Pseudomonas aeruginosa strains possessing R factor in a hospital.
    Kawakami Y; Mikoshiba F; Nagasaki S; Matsumoto H; Tazaki T
    J Antibiot (Tokyo); 1972 Oct; 25(10):607-9. PubMed ID: 4630693
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical results with amikacin (BB-K8) in surgical field (author's transl)].
    Fujimoto M; Hirao S; Ueda T; Sakai K; Shiraha Y
    Jpn J Antibiot; 1974 Apr; 27(2):234-7. PubMed ID: 4546598
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proteus rettgeri strains, resistant to gentamicin with transmissible resistance to kanamycin and carbenicillin (author's transl)].
    Urbàsková P; Torsová V; Dostàl J; Huśłavová V; Krcméry V
    Cesk Epidemiol Mikrobiol Imunol; 1977 May; 26(3):171-4. PubMed ID: 144028
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of testing immediate antibiotic disk sensitivities in bacteriuria.
    Perez JR; Gillenwater JY
    J Urol; 1973 Oct; 110(4):452-6. PubMed ID: 4582474
    [No Abstract]   [Full Text] [Related]  

  • 53. [Susceptibility of Pseudomonas aeruginosa to gentamicin, carbenicillin and framycetin].
    Abdou MA
    Arzneimittelforschung; 1973 Jun; 23(6):785-91. PubMed ID: 4199200
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation of amikacin (BB-K8) in ophthalmological field (author's transl)].
    Hatano H; Tokuda H; Kayaba C
    Jpn J Antibiot; 1974 Aug; 27(4):451-5. PubMed ID: 4548096
    [No Abstract]   [Full Text] [Related]  

  • 55. [Change of resistance and resistance status of the important pathogenic bacteria species (with consideration to carbenicillin)].
    Legler F
    Med Klin; 1970 May; 65(21):1037-9. PubMed ID: 4941397
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bacteria isolated from the urine and their antibiotic sensitivity].
    Yoshioka H; Matsumiya H; Hayashi N; Ueda K; Okudaira N
    Jpn J Antibiot; 1968 Oct; 21(5):260-6. PubMed ID: 5304361
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics.
    Klastersky J; Beumer J; Daneau D
    Pathol Biol (Paris); 1972 Sep; 20(15):643-7. PubMed ID: 4342650
    [No Abstract]   [Full Text] [Related]  

  • 59. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A rapid method of assaying gentamicin and kanamycin concentrations in serum.
    De Louvois J
    J Med Microbiol; 1974 Feb; 7(1):11-6. PubMed ID: 4604030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.